Research conducted at Dell Medical School reveals how dormant pancreatic cancer cells can weaken CAR T-cell therapy by reshaping their surroundings. The findings point to a potential strategy for overcoming treatment resistance and reducing relapse.
Dell Medical School researchers led a national study finding that COVID-19 can reactivate dormant viruses, including Epstein-Barr virus, in nearly half of hospitalized patients, even those with healthy immune systems. The findings also point to a possible link between a lesser-known family of these viruses and long COVID symptoms such as fatigue and reduced physical function.
Nicole Turgeon assumed her role as president of the American Society of Transplantation during the society’s town hall, held June 22.
Quynh Chau, Ph.D., MBA, has been named chief financial officer of Dell Medical School and the academic health system it anchors.
Dell Medical School residents and fellows showcased award-winning research, quality improvement and clinical case presentations at Research Day.
Hongfang Liu, Ph.D., will serve as the inaugural chair of the newly established Department of Quantitative and Systems Health Sciences and as chief translational AI and informatics officer for UT Dell Medical Center.
Jonathan MacClements, M.D., has been promoted to executive vice dean and appointed inaugural chief culture, professionalism and institutional integrity officer.
Meet Dell Med’s Class of 2026: six graduates whose unique paths reflect a shared commitment to redefining care in Texas and beyond.
On April 23, Dell Medical School held its annual Research Symposium and Ken Shine Awards for Excellence in Research and Research Mentorship.
CEDART program improves hospital-to-home dementia care, boosting caregiver confidence and reducing burden through community health worker support.
Whiting, appointed senior associate vice president and chief development officer for The University of Texas at Austin’s academic health system and its anchor, Dell Medical School, joins the enterprise at a defining moment.
Alison Cahill is the Society for Maternal-Fetal Medicine’s 50th president.
Paul Rathouz, a valued colleague, mentor and educator at The University of Texas at Austin, passed away Dec. 10, 2026.
Dell Medical School is one of four sites nationwide selected for a Department of Defense-funded clinical trial testing whether a rapid, drug-free brain stimulation therapy can safely relieve symptoms of postpartum depression. The study evaluates SAINT neuromodulation, an FDA-cleared therapy that has shown promising results for depression.
Nilay Shah, Ph.D., has been appointed chief strategy officer and Traci Nordberg, J.D., appointed chief human resources officer for The University of Texas at Austin’s academic health system and its anchor, Dell Medical School.
Tench and Simone Coxe’s $100 million investment — one of the largest gifts in UT history — will accelerate the development of a digitally enabled, patient-centered academic health system designed to deliver innovative care for complex conditions and advance discoveries that improve health across the state and beyond.
Amir Mian, M.D., has been named one of 60 scholars who will form the Presidential Leadership Scholars’ 11th annual class.
Pediatric emergency medicine fellow Geovonni Bell reflects on military service, advocacy and training through the Dell Medical School–Ascension Seton partnership.
This fall, seven Dell Med students were inducted into the school’s chapter of the Alpha Omega Alpha Honor Medical Society.
Claus Torp Jensen, Ph.D., has been appointed chief information officer for Dell Med and the data-enabled, technology-forward integrated academic health system it anchors.